伊弗梅克丁增加了条状胆固醇活性,以促进多巴胺终端功能
Hillary A Wadsworth1, Alicia M P Warnecke2, Joshua C Barlow1
1Department of Cellular Biology and Physiology, and Neuroscience Program, Brigham Young University, 4005 LSB, Provo, UT, 84602, USA.
伊弗梅克丁 (IVM) 通过增加多巴胺终端的兴奋性,主要是通过增强胆固醇活性来增强大脑中的多巴胺释放. 这一发现表明IVM的新机制.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊弗梅克丁 (IVM) 是一种抗寄生虫药物,已知会影响无脊椎动物的离子通道.
- IVM还调节脊椎动物的离子通道,并显示出对帕金森病治疗的临床前前景,可能通过增强L-DOPA治疗.
- 通过IVM影响多巴胺终端功能的精确机制尚未完全理解.
研究的目的:
- 为了研究伊弗梅克对多巴胺终端功能的药理作用.
- 确定纯能P2X4和尼古丁性乙胆受体在调解IVM对多巴胺释放的影响中的作用.
- 为了阐明IVM如何影响L-DOPA治疗的背景下多巴胺释放.
主要方法:
- 电化学检测被用来测量在背上条纹体中释放的多巴胺.
- 实验涉及非激活P2X4受体和对抗尼古丁受体,以评估它们在IVM影响中的作用.
- 监测了胆固醇内部神经元的发射,以评估IVM对神经元活动的影响.
- 进行了L-DOPA和IVM的同时应用,以评估对多巴胺释放的联合作用.
主要成果:
- 伊弗梅克显著增强了脊椎条纹体中多巴胺的释放.
- 静脉注射对多巴胺释放的影响并不依赖P2X4受体,而是被尼古丁受体对抗阻断.
- IVM增强了条状胆性内部神经元的发射.
- 联合L-DOPA和IVM治疗增加了多巴胺的释放,转变表明终端刺激性增强而不是囊泡含量增加.
结论:
- 伊弗梅克主要通过增强影响多巴胺终端的胆固醇活性来增加条状多巴胺释放.
- 该机制涉及终端刺激性增加,而不是膀性多巴胺含量变化.
- 这些发现突出了IVM在调节多巴胺基神经传递中的新作用,这对帕金森病研究有意义.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
08:49Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
Published on: January 12, 2012
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
